Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2. (Q36715614)
Jump to navigation
Jump to search
scientific article published on December 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2. |
scientific article published on December 2006 |
Statements
Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2 (English)
Patrizia Marini
1 December 2006